Allowing of Ivermectin for Over-the-Counter Use in Pennsylvania
In the near future, I will be introducing legislation that would allow ivermectin, a proven antiparasitic medication, to be available over the counter (OTC) in Pennsylvania. This proposal will increase access to this safe and effective medication for the treatment of various parasitic conditions and ensure that Pennsylvanians are empowered to manage their health with timely and cost-effective options.
Ivermectin is already an FDA-approved medication primarily used to treat parasitic infections, including onchocerciasis (river blindness), strongyloidiasis, scabies, and lice. It has a long history of safe use and effective benefits. Making ivermectin available over the counter for these approved uses would have a positive impact on public health and well-being, particularly in underserved and rural communities.

• Increasing Access to Critical Medication:

This legislation would ensure that residents have faster access to ivermectin, reducing wait times and dependency on healthcare providers for conditions that do not require extensive medical consultation. Many Pennsylvanians, particularly in rural and underserved communities, may struggle to access healthcare due to geographic, financial, or logistical barriers. By making ivermectin available OTC, patients could self-administer the medication for common parasitic infections, saving both time and money while avoiding unnecessary doctor visits.

• Proven Safety and Effectiveness:

Ivermectin has been extensively studied and used for decades with minimal side effects when adhering to medical guidelines. The risk of misuse is minimal for conditions like scabies and lice, where ivermectin’s topical formulations are highly effective and easy to apply.

• Supporting Public Health:

Making ivermectin available OTC could help control the spread of scabies and other parasitic diseases, especially in populations at higher risk of infection. Moreover, it could alleviate the burden on healthcare systems by preventing unnecessary emergency room visits or doctor appointments for conditions that can be easily managed with ivermectin.

• Encouraging Health Autonomy:

Allowing Pennsylvanians to access ivermectin without a prescription would empower individuals to take more control over their health, particularly for preventative care or minor conditions that do not require extensive medical intervention.
Tennessee has already passed similar legislation to make ivermectin available over the counter. Other states such as Louisiana, South Carolina, Arkansas, Missouri, and Kansas are currently considering similar initiatives. Additionally, many countries, including South Africa, Australia, Mexico, India, Brazil, Uganda, Kenya, Ghana, and Nigeria, have implemented similar laws.
It is time for Pennsylvania to join this important movement. With proven efficacy, a track record of safety, and the growing demand for accessible treatments, making ivermectin available OTC will significantly benefit our communities.
If you have any questions concerning this legislation, please contact Aaron Bashir (abashir@pasen.gov) or Donald Beishl (dbeishl@pasen.gov) in my office.
 

Statutes/Laws affected:
Printer's No. 654 (Apr 21, 2025): P.L.1700, No.699